Transposagen Biopharmaceuticals focuses on providing TKO piggyBac knockout rat and mouse models and laboratory reagents for research purposes. They supply various products including antibodies, assay kits, DNA testing, and recombinant proteins, self-described as suppliers for laboratory research.

Transposagen Biopharmaceuticals

Common Name Invalid

CPanel

LiteSpeed

CPanel SSL

Namecheap DNS

Hawk Host

Sales and Operations

Heather Ridenour

Private Kentucky Companies (Top 10K)

Southern US Companies With Fewer Than 50 Employees (Top 10K)

Medical Companies With Fewer Than 1000 Employees (Top 10K)

United States Medical Companies (Top 10K)

Transposagen Biopharmaceuticals is a privately held biotechnology company that is dedicated to providing unique animal models of human diseases for drug discovery and development. Transposagen is currently focusing on the $1.2 billion/year rodent model market. The rodent model market is experiencing double-digit annual growth due to the research and development needs of the pharmaceutical industry.

It was founded in 2003 and is headquartered in Lexington, Kentucky.

Venture Round - Transposagen Biopharmaceuticals

Grant - Transposagen Biopharmaceuticals

Lexington

Kentucky

United States

North America

Poseida Therapeutics Names Mark Gergen as CBO, CFO

Genome Editing/ Genome Engineering Market 14.5% CAGR to 2022 Led by CRISPR Technology - RnRMarketResearch

With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy

Rat Model Market by Type, Technology, Application, Service & Care Products - Forecasts to 2020 for the $600 Million Industry

Aragen Bioscience, Inc. Partners with Transposagen Biopharmaceuticals, Inc. to Launch FUT8 Knockout CHO DG44 Cell Line Development Services

Genome Editing Market Worth $3,514.08 Million by 2019

HTML5

Google Analytics

Google Tag Manager

Google Doubleclick

HubSpot Marketing Hub

Bootstrap

HubSpot Forms

Google Fonts

Microsoft Outlook

jQuery

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 20, 2024 2:51 PM	51a4cf44
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 20, 2024 2:51 PM	eae2a1ab
crunchbase trigger	general	Nov 20, 2024 2:51 PM	20b73e9e
crunchbase profile	general	Nov 20, 2024 2:54 PM	a262e6d9
li profile	general	Nov 20, 2024 2:51 PM	8d07f848
translate crunchbase fundingrounds	general	Nov 20, 2024 3:34 PM	1c727df5
peers	general	Nov 20, 2024 2:51 PM	e7908711
news basic	general	Nov 20, 2024 2:51 PM	567e8c63
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

TRAN

COM:TRANSPOSAGEN

Transposagen Biopharmaceuticals